Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Mabwell to Present the Clinical Data of 9MW2821 in Cervical Cancer as Focused Plenary Oral Presentation at 2024 Society of Gynecologic Oncology Annual Meeting on Women's Cancer 2024-03-08 22:00
TransThera Announced Global Phase 3 Clinical Trial for Cholangiocarcinoma Authorized in the European Union and Orphan Drug Designation for Tinengotinib to Treat Biliary Tract Cancer Granted by European Medicines Agency 2024-03-08 21:00
Chime Biologics Achieves ISO 27001 Certification to Strengthen Information Security in the CDMO Industry 2024-03-07 22:00
AACR 2024 | Ascentage Pharma to Present Three Preclinical Studies at 2024 American Association of Cancer Research Annual Meeting 2024-03-06 08:59
YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries 2024-03-05 21:00
WuXi Biologics Achieves Leadership Level in 2023 CDP Climate Change Assessment 2024-03-05 21:00
Landmark Clinical Approval for YOLT-201 Obtained by the NMPA 2024-03-04 20:00
NMPA Approves the NDA for CARsgen's BCMA CAR-T Therapy Zevorcabtagene Autoleucel for Relapsed or Refractory Multiple Myeloma 2024-03-01 21:50
PharmAust announces positive Phase 1 MEND Study Top-Line Results in MND / ALS 2024-02-28 20:47
FDA Grants Fast Track Designation to 9MW2821 2024-02-27 22:00
111 Announces Receipt of Withdrawal of Going Private Proposal 2024-02-27 21:58
Origin Agritech Announces Breakthrough in Corn Hybrid Development with Wild Corn Gene Integration 2024-02-27 21:30
Nona Biosciences Enters into Collaboration Agreement with Boostimmune in Antibody-Drug Conjugate Development 2024-02-27 09:23
BioCity Announces Enrollment Completion of the IgA Nephropathy (IgAN) Cohort in the Randomized, Placebo-controlled Phase II Clinical Trial of the ETA Receptor Antagonist SC0062 2024-02-26 22:38
GC Cell and BioCentriq® Execute Process Transfer Agreement in Anticipation of the U.S. entry of Immuncell-LC Inj. 2024-02-26 21:30
TransThera initiates IND-Enabling studies for TT-02332, a novel, highly potent and CNS-penetrating NLRP3 inhibitor 2024-02-26 21:00
Aucta Pharmaceuticals, Inc. ("Aucta Pharmaceuticals") launches MOTPOLY XR™ (lacosamide) extended-release capsules C-V, the first, and only once-daily formulation of lacosamide 2024-02-26 21:00
J INTS BIO, Phase 1/2 study of 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, accepted for presentation at the upcoming American Association for Cancer Research 2024 meeting in USA (AACR 2024) 2024-02-26 16:15
Oscotec/ADEL Initiates First-in-Human Dosing in Ph1 of Anti-MTBR Tau Antibody ADEL-Y01 In Alzheimer's Disease 2024-02-23 21:00
Immunofoco Announces the Dual Approval of IND Applications by the U.S. FDA and China CDE for the First EpCAM CAR-T Targeted at Advanced Solid Tumors 2024-02-23 12:51
1 24 25 26 27 28 222